Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines

Ping Gao1, Xiaoming Dong1, Yu Wang2

  • 1College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.

STAR Protocols
|April 19, 2021
PubMed
Summary

This study details an optimized CRISPR/Cas9 genome-editing protocol for creating single nucleotide mutations in cell lines. This method enhances ease of use and efficiency for genetic research, particularly for studying single nucleotide polymorphisms (SNPs).